High expression of the vascular endothelial growth factor (VEGF) is responsible for angiogenesis [55] and has been described in epithelioid sarcoma samples [56], which have found implication in the clinical utility of tyrosine kinase inhibitors, such as pazopanib; however, their efficacy is limited and is described in a further section. The gene discussed is VEGFA; the disease is epithelioid sarcoma.